BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Johnson & Johnson Completes $2 Billion Acquisition of Ambrx Biopharma, Bolstering Oncology Pipeline

Johnson & Johnson (NYSE: JNJ) announced it has successfully completed the acquisition of Ambrx Biopharma, Inc., a clinical-stage biopharmaceutica...

March 08, 2024 | News

Chime Biologics Secures ISO/IEC 27001:2022 Certification, Bolstering Information Security

Chime Biologics, a leading global CDMO that enables its partners' success in biologics,announced that it has obtained ISO/IEC 27001:2022 certification on i...

March 08, 2024 | News

SK bioscience and Sanofi to Boost Global Vaccine Supply with Major Expansion of L HOUSE Manufacturing Plant

The company will expand its manufacturing plant, L HOUSE, with additional cGMP-level facility. The new space will serve as a production base for the pne...

March 08, 2024 | News

BioGate Announces Breakthrough in Pancreatic Cancer Treatment with New Drug BGX

Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...

March 07, 2024 | News

Innovent Biologics and AnHeart Therapeutics Secure Second NDA Acceptance for Groundbreaking Lung Cancer Treatment in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

March 06, 2024 | News

BioCina and NovaCina Join Forces for Integrated Biologics Solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish...

February 28, 2024 | News

Nona Biosciences Partners with Boostimmune for Antibody-Drug Conjugate Development

The collaboration aims to leverage Nona's proprietary Harbour Mice® H2L2 (two light and two heavy chain) platform to accelerate the developm...

February 27, 2024 | News

Mabwell's Novel ADC 7MW3711 for Advanced Malignant Solid Tumors Receives FDA Clinical Trial Approval

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of B7-H3 targe...

February 21, 2024 | News

Biocytogen and Gilead Forge Landmark Collaboration to Harness Fully Human Antibody Library for Therapeutic Innovations

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a leading biotechnology company, announced a significant coll...

February 20, 2024 | News

AbbVie Bolsters Oncology Portfolio with ImmunoGen's Flagship Ovarian Cancer Treatment ELAHERE

Adds flagship antibody-drug conjugate (ADC) ELAHERE® (mirvetuximab soravtansine-gynx) for folate receptor-alpha (FR&alp...

February 16, 2024 | News

eGenesis and PorMedTec Achieve Breakthrough in Genetically Engineered Porcine Donors Production in Japan

eGenesis and PorMedTec Announce Successful Production of Genetically Engineered Porcine Donors in Japan Critical milestone in establishing eGenesis ...

February 14, 2024 | News

Multiply Labs, Thermo Fisher Expand Partnership for Cell Therapy Automation

Through integration with Multiply Labs' robotic technology, Thermo Fisher Scientific’s advanced, industry-leading cell therapy instruments, including...

February 13, 2024 | News

Samsung Biologics and LegoChem Biosciences Forge Strategic Partnership for ADC Development and Manufacturing

The collaboration marks a pivotal milestone as Samsung Biologics commits to providing cutting-edge antibody development and drug substance manufact...

February 12, 2024 | News

Aptar Partners with Biogen for Digital Health Solutions

New partnership model leverages Aptar Digital Health’s capabilities to support the development and operation of new and existing digital health sol...

February 12, 2024 | News

Stay Connected